期刊文献+

分化型甲状腺癌预后因素分析(附160例病例) 被引量:4

下载PDF
导出
摘要 目的:探讨影响分化型甲状腺癌预后的因素。方法:采用统计学单因素及多因素分析方法,研究160例分化型甲状腺癌的预后因素。结果:根据Kpalan-Meier累积生存率算法,160例患者5年、10年生存率分别为92.8%和87.1%。单因素分析显示:年龄、性别、临床分期、淋巴结转移与否、癌灶数目(单或多)均明显影响预后,多因素分析中,只有年龄、淋巴结转移与否、分期是影响预后的独立因素。结论:合理的应用预后评估系统,对分化型甲状腺癌患者采取个体化的手术方案,可改善患者的预后。
出处 《新疆医学》 2007年第1期6-9,共4页 Xinjiang Medical Journal
  • 相关文献

参考文献10

  • 1Mazzaferri EL,Jhing SM, long-time impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med,1994;95:418.
  • 2Shaha AR, Shah J P, Loree TR, Low - risk differentiated thyroid cancer: The need for selective treatent Ann Surg Oncol 1999 ; J un: 328.
  • 3Shah JP, Loree TR,Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland , Am J Surg I992;164 : 658.
  • 4Sellers M , Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg, 1992; 164: 578.
  • 5Shaha AR. Differentiated thyroid cancer: less than totol thyriodectomy. Ann Surg Oncol. 2002;7(5):379.
  • 6Sakamoto A, et al. Encapsulated papillary carcinoma of the thyroid gland: clinicopathological and cytofluorometric study in comparison with non - encapsulated papillary carcinoma.Cancer, 1993 ; 52 : 1849 - 1855.
  • 7王深明.甲状腺外科的进展与热点问题[J].中国实用外科杂志,2003,23(3):174-180. 被引量:102
  • 8Duren M, Yavuz N,Bukey Y,et al. Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: experience of an endocrine surgery center in an iodine- deficient region. World J Surg, 2000, 24 ( 11 ) : 1290 -1294.
  • 9Eroglu A, Unal M, Kocaoglu H. Total thyroidectomy for differentiated thyroid carcinoma:primary and secondary operations. Eur J Surg Oncol, 1998; 24 (4) : 283 - 287.
  • 10Segal K, Friedental R, Lubin E, et al. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg, 1995, 113(4):356 - 363.

二级参考文献27

  • 1[12]Lazarus JH, Obuobie K. Thyroid disorder-an update. Postgrad Med J, 2000, 76(899): 529
  • 2[13]Quadro L, Panariello L, Salvatore D, et al. Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab, 1994, 79(2): 590
  • 3[14]Bongarzone I, Pierotti MA, Monzini N,et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 1989, 4(12): 1457
  • 4[15]Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med, 2002, 43(9): 1188
  • 5[1]Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg, 2001, 25(3): 307
  • 6[2]Gimm O, Brauckhoff M, Thanh PN, et al. An update of thyroid surgery. Eur J Nucl Med, 2002, 29(supple 2): s447
  • 7[3]Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 1994, 97(5): 418
  • 8[4]Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab, 1992, 75(3): 714
  • 9[5]Udelsman RA. Differentiated thyroid cancer: less than total thyroidectomy. Ann Surg Oncol, 2000, 7(5): 382
  • 10[6]Shaha AR. Differentiated thyroid cancer: less than total thyroidectomy. Ann Surg Oncol. 2000, 7(5): 379

共引文献101

同被引文献80

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部